A big shareholder is picking a proxy fight, possibly leading to a sale of a little-known drug company that last year booked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results